Banner - Collaborative Care Symposium
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsViewpointsInsightsCase Based Roundtable SeriesCase StudiesCase of the QuarterPractice OwnershipRapid ReadoutVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Eva Kim, MD

Advertisement

Articles by Eva Kim, MD

Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia.

ASCRS 2025: EVO ICL in low to moderate myopia may rival LASIK

ByEva Kim, MD,Hattie Hayes,Sheryl Stevenson, Eye Care Group Editorial Director,Emily Kaiser Maharjan, Assistant Managing Editor
April 29th 2025

Eva Kim, MD, offers valuable insights into why EVO ICL is becoming a compelling alternative to traditional corneal procedures like LASIK.

Advertisement

Latest Updated Articles

  • Eva Kim, MD, shares visual outcomes of EVO implantable collamer lens in patients with low to moderate myopia.
    ASCRS 2025: EVO ICL in low to moderate myopia may rival LASIK

    Published: April 29th 2025 | Updated:



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

Some red light therapy devices may exceed safety levels for myopia control, study suggests

2

What to know about the most recent treatment and management developments in AMD

3

No myopia progression reported on average in 6-month trial assessing MiYOSMART iQ spectacle lenses

4

Comanagement to take center stage at EnVision Summit 2026

5

What Yuvezzi brings to the optometrist's clinical toolkit with Dr Derek Cunningham

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us